Swiss exchange operator SIX Group integrates SDX digital asset business to create a unified tokenization platform
ChainCatcher news, according to cryptopolitan, Swiss stock exchange operator SIX Group AG has announced that it will integrate its digital asset division, SIX Digital Exchange (SDX), into the group's main exchange and post-trade services divisions.
This move marks the end of SDX's independent brand identity. In the future, SDX's trading business will be handled by SIX's main exchange, while settlement and custody services will be transferred to SIX Securities Services. SIX Group stated that by integrating its digital asset capabilities, it aims to create a unified and robust platform to simplify processes such as trading, custody, and token issuance using blockchain technology for banks and asset management companies, thereby accelerating the growth of digital asset business and the tokenization transformation of the financial system. SIX will also continue to collaborate with the Swiss National Bank (SNB) and others to advance key projects such as wholesale central bank digital currency (CBDC).
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Janus Henderson Macro Head Says Market Is Near Its Top but Cannot Say When
A $5.7 billion patent verdict has been issued, Burford Capital (BUR.US) may receive $1.4 billion, and its share price soared by more than 12%.
Burford Capital Ltd. surged more than 12% on Monday, marking its largest intraday increase since the end of March, after a federal jury delivered a verdict in a patent case involving Apple.
Pfizer (PFE.US), BioNTech (BNTX.US), and Moderna (MRNA.US) seek dismissal of Bayer’s Monsanto mRNA patent lawsuit, but the judge rejects the request
A federal judge in Delaware on Monday rejected the requests from Pfizer, BioNTech, and Moderna to dismiss a lawsuit filed against them by Monsanto, a subsidiary of the German pharmaceutical giant Bayer. The lawsuit concerns these pharmaceutical companies' use of a patent related to mRNA technology.
After years of waiting and another delay, Tesla (TSLA.US) postpones the Roadster debut to October 15 as severe weather forces the event to stop.
Tesla has rescheduled the unveiling event for its next-generation Roadster, originally planned for this week, to October 15.
